Abstract
Purpose: Intravitreal implantation of dexamethasone implant (Ozurdex®) is being widely used for the treatment of macular edema (ME) after branch or central retinal vein occlusion, diabetic ME, and persistent ME associated with uveitis or Irvine-Gass syndrome. We describe a complication: migration of the dexamethasone implant into the anterior chamber through basal iridectomy (Ando) in a pseudophakic patient with development of corneal edema and secondary high intraocular pressure. Methods: This is a case report of migration of Ozurdex® through basal iridectomy in a pseudophakic patient with iris claw lens. Conclusions: Pseudophakic patients, with a history of vitrectomy, even those with a basal iridectomy (Ando), are at high risk for migration of the Ozurdex® into the anterior chamber and development of corneal edema.
Original language | English |
---|---|
Pages (from-to) | e52 - e54 |
Journal | European Journal of Ophthalmology |
Volume | 26 |
Issue number | 3 |
DOIs | |
Publication status | Published - Nov 25 2015 |
Keywords
- Ando iridectomy
- Dexamethasone implant
- Migration
- Ozurdex®
ASJC Scopus subject areas
- Medicine(all)
- Ophthalmology